Helius Medical Technologies, Inc. Stock Toronto S.E.
Equities
HSM
US42328V1089
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +4.21% | -.--% |
Apr. 24 | Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center | CI |
Apr. 03 | Top Premarket Gainers | MT |
Sales 2024 * | 977K 1.35M | Sales 2025 * | 5.72M 7.87M | Capitalization | 11M 15.15M |
---|---|---|---|---|---|
Net income 2024 * | -11M -15.15M | Net income 2025 * | -9M -12.39M | EV / Sales 2024 * | 11.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.92 x |
P/E ratio 2024 * |
-0.39
x | P/E ratio 2025 * |
-0.93
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.15% |
Latest transcript on Helius Medical Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Dane Andreeff
CEO | Chief Executive Officer | 58 | 17-08-03 |
Director of Finance/CFO | 63 | 20-06-08 | |
Chief Tech/Sci/R&D Officer | 57 | 21-07-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Straw
BRD | Director/Board Member | 85 | 14-11-17 |
Dane Andreeff
CEO | Chief Executive Officer | 58 | 17-08-03 |
Blane Walter
CHM | Chairman | 53 | 15-12-28 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.15% | 220B | |
+6.60% | 183B | |
+9.86% | 133B | |
+24.32% | 107B | |
-0.95% | 63.05B | |
+11.04% | 51.74B | |
+4.81% | 50.47B | |
-1.43% | 40.91B | |
+24.40% | 31.91B |
- Stock Market
- Equities
- HSDT Stock
- HSM Stock